COMPANY
Artax Biopharma
Timeline
- Trial start Phase 1/Phase 2: Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis source ↗
- Trial start Phase 1: A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses source ↗
- Trial start Phase 1: Potential Food Effect And Repeated Dosing of AX-024.HCl In Healthy Subjects source ↗
- Trial start Phase 1: Safety Study of Immune System Modulator for Autoimmune Diseases source ↗
Clinical trials (lead sponsor) 4
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05725057 | Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis | Phase 1/Phase 2 | Completed | Nov 30, 2023 | Sep 4, 2024 (actual) |
| NCT05218434 | A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses | Phase 1 | Completed | Nov 17, 2021 | Nov 16, 2022 (actual) |
| NCT02546635 | Potential Food Effect And Repeated Dosing of AX-024.HCl In Healthy Subjects | Phase 1 | Completed | 2015-08 | 2015-12 (actual) |
| NCT02243683 | Safety Study of Immune System Modulator for Autoimmune Diseases | Phase 1 | Completed | 2014-09 | 2014-11 (actual) |